Hello, dear GQ community!

Due to my still quite small portfolio with TR, I have now decided to sell it completely after the successful restart in Switzerland and start a new chapter with Swissquote.

Now to the problem: I was able to sell all positions smoothly, except for $AVGO (+0.25%) & $NOVO B (+0.99%)

I can only buy these or create a savings plan.

Are you aware of anything similar?

News flow + magic €50 mark.

The story fits very well at the moment.

I expect that we will reach the 50€ sustainably at $NOVO B (+0.99%)
can be broken. The news came out yesterday aftermarkets, the stock shot up, but could not hold the gains and came back today towards the 50€, which is an ideal opportunity for an entry.

For all those who were looking for an entry here. The share is very news-driven, but this is definitely a level that is very interesting for a trade and where you can place the stops very close to the entry below the €50 mark.

Trading idea:

• Entry 50€
• Stop 49€
• Risk-reward ratio (R:R): 8:1

The dead live longer.

$NOVO B (+0.99%) surprised with strong news yesterday and the share jumped above the 50€ mark.

The exciting question: Are we seeing a turnaround here or is it just a brief blip?

• Oral semaglutide 25 mg (Wegovy® pill) has the primary endpoints in the large Phase 3 study OASIS 4 study.
• Results after 64 weeks (approx. 1.2 years):

-> 16.6 % weight loss on average with the pill vs. 2.7 % with placebo

-> One third of the participants even lost ≥20 % of the body weight

• If you exclude patients who discontinued the therapy, it was 13.6 % vs. 2.2 %
• Additional benefit: Improvement of cardiovascular risk factors (blood pressure, blood lipids, etc.) and more physical activity
• Side effects: similar to the injected Wegovy version (mostly gastrointestinal complaints)

FDA approval for chronic weight loss is expected at the end of 2025, production production in the USA is already underway.

#aktie
#börse
#novonordisk
#investieren
#wegovy
#abnehmen
#glp1
#fda

I would like to start a completely new portfolio that will primarily revolve around dividends.

As a core I was thinking of $TDIV (-0.1%)

Would you say this is a good core?

If not I would add $VHYL (+0.15%) add.

Additionally I would like to have a CC ETF as a kind of support, probably $JEGP (+0.18%) and or $SXYD (-0.06%)

I would like to represent the NASDAQ with $EQQQ (+0.1%) but I will represent it with $ASML (+0.62%) and $2330 will be added.

Allianz $ALV (+0.23%) and Munich Re $MUV2 (-0.19%) I definitely want to include, but they are too expensive for me financially, so I was thinking of the $EXH5 (+0.01%)

Oil shares are represented by $VAR (-1.12%) and one more.

Do you have any recommendations?

I am thinking about $CVX (-0.11%)
$EQNR (+0.33%) and $PETR4 (-0.05%)

I would also like renewable energies, but I'm not familiar with them.

Do you have any suggestions?

Becoming a defensive company $ULVR (-0.32%)
$D05 (-0.75%)
$O (+0.22%) and of course $NOVO B (+0.99%) Being.

$BATS (+0.32%) I already have in a portfolio, would it be too much of a lump to add $MO (+0.28%) to add to it?

I still have $KHC (+0.01%) on the watchlist but the split is not going so well, would it be wise to start with a savings plan?

Apart from that $RIO (-0.32%)
$NKE (+0.37%)
$1211 (-0.14%)
$SOFI (+0.63%) and $HAUTO (-1.07%) will be represented with smaller positions.

What is your opinion?

Would you improve anything?

What else would you add, especially in EE and defensive stocks?

Feedback is very important to me here, so far I have just been wandering aimlessly around the stock market without a fixed plan and strategy.

This is my first attempt to build something serious.

Greetings to all Getquins out there!

In the end, I actually decided on neither of them.

No industry that appeals to me.

$NOVO B (+0.99%) vs $LLY (+0.11%)

s/o on @Tenbagger2024 in the commis 🫡

Small repeat purchase